August 11, 2016: A recent Medscape article regarding the increased prevalence of ASIA syndrome. To read the full article, click here.
Dr Shoenfeld elaborated on ASIA syndrome in a 2013 interviewwith BioMed Central.
“The idea of ASIA as a new syndrome developed after some studies on Gulf War syndrome reported that soldiers who had not been deployed to the Gulf area were suffering from symptoms such as severe fatigue, cognitive impairment, myalgias and arthralgias. This raised the question of whether it was the vaccines administered to the soldiers that induced these syndromes,” Dr Shoenfeld commented in that interview. His team first used the term “ASIA syndrome” in a report of 93 cases of what was being described as Gulf War syndrome in individuals who had received hepatitis B vaccination (Lupus. 2012;21:146-152).
Dr Shoenfeld noted that the most common adjuvants are silicone implants (such as used for breast augmentation) and aluminum in vaccines.
He emphasized that he is “definitely not against vaccines! Vaccines are the best medical development that humankind has had in the last 300 years, and have helped to bring about almost complete eradication of some viral diseases. However, it should be considered that when you give millions of people an active substance, and vaccines are active substances, then some may suffer from adverse events. After all, vaccines contain viral or synthetic particles emulsified in adjuvant, which is supposed to enhance the immune reaction.”
“So, we have to identify the people who are at risk of suffering from side effects due to the chronic stimulation of their immune system,” he continued. “First of all we have to diagnose them, to treat them — and some of them should be compensated, because the vaccines are quite often imposed on them either by the state, the government, or by the employer.”
“With regard to the ASIA syndrome, prevalence is higher in subjects that carry the gene HLA-DRB1,” he noted. “Maybe in the future with further advances in personalized medicine, we will be able to screen those at risk based on their genetic composition, and therefore avoid onset of autoimmune diseases by avoiding administration of vaccines containing adjuvants that are known to be associated with the ASIA syndrome.”